Hizentra® CIDP - Key Publications | CSL Behring Medical Affairs

Have a Question? Use Our New Chat Feature! Chat with our Medical Information Specialists by clicking on the Chat with us now available in the lower right corner of this screen.

Product Information	Educational Materials	Conferences and Events	Key Publications

Posters

Successful simulation of infusion pump use for IgPro20 prefilled syringes

View Poster

Please see full prescribing information for Hizentra

Real-world experience of needle length use based on BMI for IgPro20 administration

View Poster

Please see full prescribing information for Hizentra

Key Publications

Immunoglobulin Therapy for Chronic Inflammatory Demyelinating Polyneuropathy: Synopsis of PRIMA, PATH, and PATH-OLE Studies

^{Click Image to view Graphical Abstract}

Léger 2013
van Schailk 2017
van Schailk 2019
Request | Ask a Question | View Article: PRIMA | View Article: PATH | View Article PATH-OLE

Subcutaneous Immunoglobulin for maintenance treatment in CIDP (PATH): a randomized, double-blind, placebo-controlled, phase 3 trial

van Schaik, IN et al
Lancet Neurol, 2017
Request | Ask a Question | View Article

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH study): study protocol for a randomized controlled trial.

van Schaik, IN et al
Trials, 2016
Request | Ask a Question | View Article

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP

Van Schaik, IN et al
Neurol NeuroimmunolNeuroinflamm, 2019
Request | Ask a Question | View Article

Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label phase III study (PRIMA)

Léger, J-M et al
J Periph Nerv Syst 2013
Request | Ask a Question | View Article

Restabilization treatment after IVIg withdrawal in chronic inflammatory demyelinating polyneuropathy. Results from the pre-randomization phase of the PATH study

Mielke, O et al
J Periph Nerv Syst 2019
Request | Ask a Question | View Article